MicroRNAs as the critical regulators of cisplatin resistance in gastric tumor cells

Combined chemotherapeutic treatment is the method of choice for advanced and metastatic gastric tumors. However, resistance to chemotherapeutic agents is one of the main challenges for the efficient gastric cancer (GC) treatment. Cisplatin (CDDP) is used as an important regimen of chemotherapy for G...

Descripción completa

Detalles Bibliográficos
Autores principales: Zangouei, Amir Sadra, Moghbeli, Meysam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182944/
https://www.ncbi.nlm.nih.gov/pubmed/34099061
http://dx.doi.org/10.1186/s41021-021-00192-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182944/
https://www.ncbi.nlm.nih.gov/pubmed/34099061
http://dx.doi.org/10.1186/s41021-021-00192-4

Ejemplares similares